Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Atacicept
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 13, 46, 49, 66 💬
2Atacicept 150 mg
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 13, 49 💬
3Atacicept 25 mg
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 13, 66 💬
4Atacicept 75 mg
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 13, 49, 66 💬
5Atacicept 75 milligram (mg)
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
6Atacicept: with loading dose
(D09704)		[1] Atacicept[1] Atacicept (D09704) 💬[2] TNFSF13,
TNFSF13B 💬		[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 46 💬